Farmacocinética y farmacodinamia de antimicrobianos: a propósito de pacientes con neutropenia y fiebre
Garzón, Javier R; Cuervo M, Sonia; Gómez R, Julio; Cortés, Jorge A.
Rev. chil. infectol
; 28(6): 537-545, dic. 2011. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-612152
Documentos relacionados
[Pharmacokinetics and pharmacodynamics of antibacterial agents: on account of febrile neutropenic patients].
Infectious events after endoscopic procedures in patients with neutropenia and hematologic diseases.
Pediatric Benign Neutropenia: Assessing Practice Preferences in Canada.
Improving management of fever in neutropenic children with cancer across multiple sites.
Non-neutropenic fever in children with cancer: Management, outcomes and clinical decision rule validation.
[Time to Antibiotics (TTA) - Reassessment from the German Working Group for Fever and Neutropenia in Children and Adolescents (DGPI/GPOH)].
Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.
Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic-pharmacodynamic analysis.
Factors associated with the use of antibiotics for children presenting with illnesses with fever and cough obtained from prescription and non-prescription sources: a cross-sectional study of data for 37 sub-Saharan African countries.
The Management of Young Children With a Likely Infectious Condition Presenting Moderate to Severe Neutropenia.